CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 84 enrolled
Drug / intervention
Low Field Magnetic Stimulation (LFMS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01654796
NCT01654796N/ACompleted
CompareCT.gov

Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Massachusetts General Hospital·interventional·Posted Aug 1, 2012·Updated Sep 5, 2017

In Brief

A clinical study evaluating Low Field Magnetic Stimulation (LFMS) and Sham LFMS for Treatment Resistant Depression. Completed, enrolled 84 participants across 6 sites.

Detailed Summary

This study is looking at the safety and efficacy of low field magnetic stimulation (LFMS) for treating patients with treatment resistant depression who are taking an antidepressant that is not working for them.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTreatment Resistant Depression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH), Yale University, Icahn School of Medicine at Mount Sinai, University of Texas Southwestern Medical Center, University of Alabama at Birmingham, Emory University

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 1, 2012
Enrollment StartApr 1, 2013
Primary CompletionMay 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 13.9 years ago

Interventions

Low Field Magnetic Stimulation (LFMS)device

The LFMS devices produces a unique magnetic field that may help alleviate symptoms of depression.

Sham LFMSdevice

Sham LFMS looks and sounds like the active treatment but does not produce any magnetic stimulation.